CircGAB1 Facilitates Podocyte Injury Through Sponging miR-346 and Activating MAPK6 in Diabetic Nephropathy

Pingyue Ma1, Yajing He1, Benyong Wang1

  • 1Department of Nephrology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, No.261, Huansha Road, Hangzhou, Zhejiang, 310006, P. R. China.

Abstract

Insights

Circular RNA GAB1 (circGAB1) exacerbates diabetic nephropathy by promoting podocyte injury. CircGAB1 targets microRNA-346 (miR-346) to upregulate mitogen-activated protein kinase 6 (MAPK6), driving disease progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pathology

Background:

  • Diabetic nephropathy (DN) is a severe complication of diabetes characterized by progressive kidney damage.
  • Podocyte injury is a critical event in the advancement of DN.
  • Circular RNAs (circRNAs) are emerging as key regulators in the pathogenesis of DN.

Purpose of the Study:

  • To investigate the role and underlying mechanism of circGAB1 in the progression of diabetic nephropathy.
  • To elucidate the interaction between circGAB1, microRNA-346 (miR-346), and mitogen-activated protein kinase 6 (MAPK6) in podocyte injury.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure circGAB1, miR-346, and MAPK6 expression.
  • Cell viability (CCK8 assay) and apoptosis (flow cytometry) assays.
  • Western blot for protein analysis, ELISA for inflammatory factors, and oxidative stress marker detection.
  • Dual-luciferase reporter assay to confirm molecular interactions.

Main Results:

  • CircGAB1 expression was significantly upregulated in DN serum samples and high glucose-treated podocytes.
  • Knockdown of circGAB1 attenuated high glucose-induced podocyte apoptosis, inflammation, and oxidative stress.
  • CircGAB1 acted as a molecular sponge for miR-346, inhibiting its function, and miR-346 directly targeted MAPK6.
  • Overexpression of miR-346 or inhibition of circGAB1 protected against podocyte injury, while a miR-346 inhibitor reversed the protective effects of circGAB1 knockdown.

Conclusions:

  • CircGAB1 promotes podocyte injury and potentially diabetic nephropathy progression by modulating the miR-346/MAPK6 axis.
  • CircGAB1 serves as a crucial regulator in the pathogenesis of DN, highlighting its potential as a therapeutic target.

Related Concept Videos